Package Leaflet: Information for the Patient
Pharmagrip Cough and Congestionpowder for oral solution
Paracetamol / Pseudoephedrine sulfate / Dextromethorphan hydrobromide
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Follow the instructions for administration of the medicine contained in this leaflet or as indicated by your doctor or pharmacist.
Contents of the Package Leaflet
Paracetamol belongs to the group of medicines called analgesics and antipyretics, which reduces pain and fever. Pseudoephedrine belongs to the group of medicines called nasal decongestants. Dextromethorphan belongs to the group of medicines called antitussives.
This medicine is indicated for the symptomatic relief of colds and flu that are accompanied by pain, fever, nasal congestion, and unproductive cough (irritative and nervous). For individuals over 12 years of age.
You should consult a doctor if your symptoms worsen or do not improve or if the fever persists for more than 3 days or the pain or other symptoms persist for more than 5 days.
This medicine can cause dependence. Therefore, treatment should be of short duration.
There is a possibility that one of the active ingredients in Pharmagrip Cough and Congestion, pseudoephedrine, may be abused. Large doses of pseudoephedrine can be toxic. Continuous use can lead to tolerance and may cause you to take more Pharmagrip Cough and Congestion than the recommended dose to achieve the desired effect, which could lead to an increased risk of overdose. Do not exceed the maximum recommended dose or treatment duration (see section 3).
Do not takePharmagrip Cough and Congestion
Warnings and precautions
Consult your doctor or pharmacist before starting to take Pharmagrip Cough and Congestion.
Due to its Paracetamolcontent:
Due to its Pseudoephedrinecontent:
With Pharmagrip Cough and Congestion, blood flow to the optic nerve may be reduced. If you experience sudden loss of vision, stop taking Pharmagrip Cough and Congestion and contact your doctor or seek immediate medical attention. See section 4.
Cases of posterior reversible encephalopathy syndrome (PRES) and reversible cerebral vasoconstriction syndrome (RCVS) have been reported after the use of medicines containing pseudoephedrine. PRES and RCVS are rare diseases that may involve reduced blood flow to the brain. Stop using Pharmagrip Cough and Congestion immediately and seek immediate medical attention if you experience symptoms that may be signs of PRES or RCVS (to know the symptoms, see section 4 "Possible side effects").
Sudden abdominal pain or rectal bleeding may occur with the use of Pharmagrip Cough and Congestion due to inflammation of the colon (ischemic colitis). If these gastrointestinal symptoms appear, stop taking Pharmagrip Cough and Congestion and contact your doctor or seek immediate medical attention. See section 4.
Due to its Dextromethorphancontent:
Cases of abuse with medicines containing dextromethorphan have been described in adolescents. Therefore, this possibility should be taken into account, as serious adverse effects may occur (see "If you take more Pharmagrip Cough and Congestion than you should").
Children and adolescents
Do not use in children under 12 years of age.
Other medicines andPharmagrip Cough and Congestion
Inform your doctor or pharmacist if you are taking, have recently taken, or may take any other medicine.
Interactions due to paracetamol
Also, inform your doctor or pharmacist if you are taking:
-flucloxacillin (antibiotic), due to a serious risk of alteration of blood and fluids (called metabolic acidosis with high anion gap) that should be treated urgently (see section 2).
Interactions due to pseudoephedrine
Do not take this medicine during treatment or in the 2 weeks following treatment with medicines of the type of monoamine oxidase inhibitors (MAOIs) such as those listed below, as adverse effects such as severe hypertension, arrhythmias, vomiting, and headache may occur:
Do not take this medicine with other medicines for relieving nasal congestion.
If you are using any of the following medicines, it may be necessary to modify the dose of one of them or interrupt treatment:
Interactions due to dextromethorphan
Do not take this medicine during treatment or in the 2 weeks following treatment with medicines of the type of:
If you are using any of the following medicines, it may be necessary to modify the dose of one of them or interrupt treatment:
Interference with laboratory tests:
If you are going to have any laboratory tests (including blood, urine, etc.), inform your doctor that you are taking this medicine, as it may alter the results of these tests.
TakingPharmagrip Cough and Congestionwith food, drinks, and alcohol
The use of paracetamol in patients who habitually consume alcohol (3 or more alcoholic beverages per day) may cause liver damage. |
Limit the consumption of beverages containing caffeine (coffee, tea, chocolate, and cola-based drinks) while taking this medicine.
Do not consume alcoholic beverages during treatment, as this may increase the occurrence of adverse reactions.
Do not take with grapefruit or bitter orange juice.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.
Do not use Pharmagrip Cough and Congestion, due to pseudoephedrine, during the first trimester of pregnancy, as it may cause malformations of the digestive system and face of the newborn, with a higher risk in smoking women, and during the remaining months of pregnancy, only under medical prescription.
Breastfeeding women should not take this medicine, as paracetamol passes into breast milk and pseudoephedrine also in small amounts, which may cause adverse effects in the infant.
Driving and using machines
On rare occasions, during treatment, drowsiness and dizziness may occur, so if you notice these symptoms, you should not drive vehicles or operate hazardous machinery.
Pharmagrip Cough and Congestioncontains sucrose
This medicine contains sucrose. If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medicine.
Pharmagrip Cough and Congestion contains sorbitol (E-420)
This medicine contains 10 mg of sorbitol (E-420) in each sachet.
Pharmagrip Cough and Congestion contains amaranth (E-123)
This medicine may cause allergic reactions because it contains amaranth (E-123). It can cause asthma, especially in patients allergic to acetylsalicylic acid.
Pharmagrip Cough and Congestioncontains sodium
This medicine contains 60.84 mg of sodium (main component of table salt) in each sachet. This is equivalent to 3% of the maximum recommended daily intake of sodium for an adult.
Follow the administration instructions of the medicine contained in this prospectus or as indicated by your doctor or pharmacist. In case of doubt, ask your doctor or pharmacist.
The recommended dose is:
Adults:the recommended dose is 1 sachet every 4, 6, or 8 hours (6, 4, or 3 times a day) as needed. Do not take more than 3 grams of paracetamol (6 sachets) in 24 hours. See the "Warnings and precautions" section.
Adolescents (from 12 years old) weighing over 43 kg:the recommended dose is 1 sachet 3 or 4 times a day, as needed. The doses should be spaced at least 4 hours apart. Do not exceed 5 sachets every 24 hours.
Patients with liver or kidney disease: must consult their doctor before taking this medicine. If your doctor prescribes this medicine, you should wait at least 8 hours between two doses.
People over 60 years old: the dosage should be established by the doctor, as it may be necessary to reduce the usual dose.
Use in children and adolescents
This medicine is not indicated for children under 12 years old.
This medicine is administered orally.
Pour the contents of a sachet into a half glass of water and stir until it is completely dissolved.
Take once dissolved.
If the medicine is taken at night, it should be taken a few hours before bedtime to reduce the possibility of insomnia in patients with difficulty sleeping.
The administration of this medicine is subject to the appearance of pain or fever. As these disappear, this medication should be suspended.
If the fever persists for more than 3 days, the pain for more than 5 days, or the symptoms worsen or others appear such as high fever, skin rash, or persistent headache, you should consult a doctor.
If you take morePharmagrip cough and congestionthan you should
You should consult your doctor or pharmacist immediately.
The symptoms of paracetamol overdose can be: dizziness, vomiting, loss of appetite, yellowing of the skin and eyes (jaundice), abdominal pain, and kidney and liver disorders.
If you have taken an overdose, you should go to a medical center immediately, even if you do not notice the symptoms, since they often do not appear until 3 days after ingestion of the overdose, even in cases of severe poisoning.
Patients undergoing treatment with barbiturates or chronic alcoholics may be more susceptible to the toxicity of a paracetamol overdose.
The symptoms of pseudoephedrine overdose include stimulation of the nervous system and heart: rapid breathing, excitement, nervousness, irritability, restlessness, tremors, convulsions, hallucinations, irregular heartbeats (slow or fast) severe or continuous, increased blood pressure, severe or continuous breathing difficulties, and difficulty urinating. In elderly patients, serious adverse effects such as hallucinations, central nervous system depression, or convulsions have been reported. In more severe cases, it can cause: decreased potassium in the blood (hypokalemia), mental disorder with altered perception of reality (psychosis), convulsions, coma, and hypertensive crises.
In the case of a dextromethorphan overdose, you may experience confusion, excitability, nervousness, and restlessness, among other effects, depending on the dose.
In children, the accidental ingestion of very high doses can cause hallucinations (visions or hearings that are not present), hysteria, facial inflammation, nausea, vomiting, drowsiness, nervousness, and gait disturbances, among other symptoms.
There have been cases of abuse with medicines containing dextromethorphan in adolescents, which can cause serious adverse effects, such as: mental and emotional changes, which can include anxiety, depression, and psychosis (mental illness).
Treatment of overdose is more effective if started within 4 hours of taking the medicine.
If you take more Pharmagrip cough and congestion than indicated, you may experience the following symptoms: nausea and vomiting, involuntary muscle contractions, agitation, confusion, drowsiness, disorders of consciousness, rapid and involuntary eye movements, cardiac disorders (accelerated heart rate), coordination disorders, psychosis with visual hallucinations, and hyperexcitability.
Other symptoms in case of massive overdose may be: coma, severe respiratory problems, and convulsions.
Contact your doctor or hospital immediately if you experience any of the mentioned symptoms.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service, phone 91 562 04 20, indicating the medicine and the amount taken.
If you forgot to takePharmagrip cough and congestion
Do not take a double dose to make up for the forgotten doses. If necessary, take the medicine again as indicated in section 3. "How to take Pharmagrip cough and congestion".
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
Side effects due to Paracetamol:
Rare (may affect up to 1 in 1,000 people) are: discomfort, low blood pressure (hypotension), and increased levels of transaminases in the blood.
Very rare (may affect up to 1 in 10,000 people) are: kidney disease, cloudy urine, allergic dermatitis (skin rash), jaundice (yellowing of the skin), blood disorders (agranulocytosis, leucopenia, neutropenia, hemolytic anemia), and hypoglycemia (low blood sugar).
Frequency not known (cannot be estimated from the available data): a serious disease that can make the blood more acidic (called metabolic acidosis) in patients with severe disease using paracetamol (see section 2).
Very rare cases of serious skin reactions have been reported.
Paracetamol can damage the liver when taken in high doses or in prolonged treatments.
Side effects due to Pseudoephedrine:
During the period of use of pseudoephedrine, the following side effects have been reported, whose frequency cannot be established with precision:
Severe side effects (frequency not known): serious diseases that affect the blood vessels of the brain, known as posterior reversible encephalopathy syndrome (PRES) and reversible cerebral vasoconstriction syndrome (RCVS).
Stop using Pharmatusgrip immediately and seek urgent medical attention if you present symptoms that may be signs of posterior reversible encephalopathy syndrome (PRES) and reversible cerebral vasoconstriction syndrome (RCVS). These include:
More frequently, the following may occur: symptoms of central nervous system stimulation, including sleep disorders, nervousness, restlessness, muscle tremors, anxiety, and taste distortion.
Less frequently, the following may occur: hyperactivity, hyperexcitability, dizziness, headache, ataxia (movement disorder), tremors, dilated pupils, tachycardia, palpitations, hypertension (mainly in hypertensive patients), nausea, vomiting, intestinal inflammation with frequent diarrhea (ischemic colitis), red hardened skin rashes with itching, skin inflammation, difficulty or pain when urinating, increased sweating, unusual paleness, and weakness.
In rarer cases, the following may occur: hallucinations (more frequent with high doses), nightmares, screaming, and confusion in children, convulsions, arrhythmias, and bradycardia (very rapid or very slow heartbeats, more frequent with high doses), myocardial infarction (very rare), breathing difficulties.
Frequency not known(cannot be estimated from the available data): colon inflammation due to insufficient blood irrigation (ischemic colitis), decreased blood flow to the optic nerve (ischemic optic neuropathy).
Side effects due to Dextromethorphan:
During the period of use of dextromethorphan, the following side effects have been observed, whose frequency cannot be established with precision:
Reporting of side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this prospectus. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es/. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
Do not store at a temperature above 25°C.
Medicines should not be thrown down the drain or into the trash. Deposit the packaging and medicines that you no longer need in the SIGRE Point of the pharmacy. In case of doubt, ask your pharmacist how to dispose of the packaging and medicines that you no longer need. This way, you will help protect the environment.
Composition of Pharmatusgrip
Appearance of the product and package contents
Pharmatusgrip powder for oral solution is a pink powder for oral solution with a strawberry flavor.
Each package contains 10 or 20 single-dose sachets.
Only some package sizes may be marketed.
Marketing authorization holder and manufacturer
Marketing authorization holder:
Laboratorios Cinfa, S.A.
Carretera Olaz-Chipi, 10. Polígono Industrial Areta
31620 Huarte (Navarra) - Spain
Manufacturer:
FARMALIDER, S.A.
C/ Aragoneses, 2
28108 (Alcobendas) Madrid
Spain
or
TOLL MANUFACTURING SERVICES S.L.
C/ Aragoneses, 2
28108 Alcobendas, Madrid (Spain)
or
Laboratorios Cinfa, S.A.
Carretera Olaz-Chipi, 10. Polígono Industrial Areta
31620 Huarte (Navarra) – Spain
or
Lamp San Prospero SPA
Via della Pace, 25/A,
41030, San Prospero (Modena)
Italy
Date of the last revision of this prospectus:March 2025
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/